New drug shows promise in easing bulging eyes from thyroid disease
NCT ID NCT06126783
First seen May 05, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This study followed up on people who had already received IBI311 for thyroid eye disease, a condition that causes eye bulging and discomfort. Researchers wanted to see if the drug continued to work safely over time. A total of 91 adults took part, and the main goal was to measure how many had a meaningful reduction in eye bulging.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE (TED) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.